Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
29 May, 1996 - 12 June, 1996
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guidelineopen allclose all
according to guideline
OECD Guideline 402 (Acute Dermal Toxicity)
according to guideline
EU Method B.3 (Acute Toxicity (Dermal))
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
Didecyldimethylammonium chloride
EC Number:
EC Name:
Didecyldimethylammonium chloride
Cas Number:
Molecular formula:
C22H48N Cl
didecyldimethylammonium chloride
Details on test material:
The test substance contains ca. 50% didecyldimethylammonium chloride (CAS no.: 7173-51-5) and 20% isopropanol (CAS no.: 67-63-0) in

Test animals

Details on test animals or test system and environmental conditions:
Species: Rat
Strain: Wistar strain Crl:(WI) BR (outbred, SPF-quality)
Source: Charles River, Sulzfeld, Germany.
Sex: Males and females
Age/weight at study initiation: Approx. 9 weeks, 373 g (mean males) and 240 g (mean females)
Number of animals per group: 5 males and 5 females
Control animals: No

Administration / exposure

Details on dermal exposure:
Postexposure period: 15 days
Type: Dermal
Concentration: 2000 mg/kg bw for 24 hours (dose volume: 10 ml/kg in distilled water)
Vehicle: Distilled water
Concentration in vehicle: 200 mg/ml (20%)
Total volume applied: 10 ml/kg
Controls: No
Limit test at 2000 mg/kg bw.
No. of animals per sex per dose:
Control animals:

Results and discussion

Effect levels
Key result
Dose descriptor:
Effect level:
> 1 000 mg/kg bw
Based on:
act. ingr.
Clinical signs:
other: Lethargy was noted in all animals, between days 2 and 4. Hunched posture was observed in four females between days 2 and 6. Skin effects in the treated area: Swelling, necrosis and hardening of the back, scabs and brown skin on the back were noted in all
Gross pathology:
No abnormalities were found at macroscopic post mortem examination Of the animals.
Other findings:
At removal of the bandages (day 2) it was noticed that the bandages of two Females (number 9 and 10) had shifted caudally. The clinical signs shown by these animals were not significantly different compared to the other females. The exposure to the test substance was therefore considered sufficient.

Any other information on results incl. tables

No mortality occurred. Effects noted were lethargy in all animals between day 2 and 4 and skin effects which consisted
of swelling, redness, erythema and necrosis of the skin. The majority of the skin effects persisted until the end of the
observation time. No abnormalities were found at macroscopic post mortem examination.

Applicant's summary and conclusion

Interpretation of results:
other: Category 4 based on EU CLP criteria
The acute dermal LD50 of the test substance in rats was determined to be >2000 mg/kg bw (i.e. >1000 mg a.i./kg bw).
Executive summary:

A study performed according to GLP and OECD 402 and EU B.3 “Acute Dermal Toxicity”. Five male and five female rats received a dermal dose of 2000 mg/kg bw for 24 h (dose volume: 10 ml/kg in distilled water) under occlusive dressing for 24 h. One day before exposure (day -1) an area of approximately 5x7 cm on the back of the animal was clipped. 24 h, after which dressings were removed and residual test substance removed using a tissue moistened with tap water. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed after terminal sacrifice on day 15. No mortality occurred. Effects noted were lethargy in all animals between day 2 and 4 and skin effects which consisted of swelling, redness, erythema and necrosis of the skin. The majority of the skin effects persisted until the end of the observation time. No abnormalities were found at macroscopic post mortem examination. Effects are limited to local irritation/corrosion of the skin, without involvement of systemic toxicity. The acute dermal LD50 of the test substance in rats were determined to be >2000 mg/kg bw (i.e. >1000 mg a.i./kg bw).

As quaternary ammonium compounds do not easily pass biological membranes, dermal absorption of these compounds is very limited. The dermal toxicity of aqueous DDAC solutions is related to its corrosivety and therefore more related to the concentration of the administered solution then of the actual amount in mg/kg. Due to the direct corrosive effect, there is danger of irreversible damage to the skin upon exposure to the undiluted solution. Further toxicity is secondary to the local tissue damage, rather than the result of percutaneously absorbed material. Some reviews mention comparable dermal LD50 data in rat from literature which is in the range 2000 – 3000 mg/kg bw.

Toxicity is related to concentration dependent cytotoxicity, with a lack of specific systemic toxicity. The toxicity (and efficacy as based on same mechanism of action) show a dependence on chain length, with an optimum at C10-C12. Therefore this test using C10-chainlength can be seen as worst case representative for the whole group of DDAC compounds between C8 and C18. Furthermore, additional tests for acute dermal toxicity are not ethical due to its corrosive effects and can thus not be performed.